All coverage
FDA approves esketamine, the first major depression treatment to reach U.S. market in decades
By Megan Thielking
FDA Approves Johnson & Johnson's Ketamine-Derived Drug For Treatment-Resistant Depression
By Ellie Kincaid
FDA approves ketamine-like nasal spray for depression
By Debra Goldschmidt